Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CyberGene Aktiebolag
AB
Active
Org 5565045019
Banvaktsvägen 22, 171 48
Solna
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 1995
2 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
CyberGene Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
BM
Bo Magnus Lagerberg
Chief Auditor
Chief Auditor
2026
ÅA
Åsa Anita Dahlgren
Chief Auditor
Chief Auditor
2022
PJ
Per Joakim Grånemo
Chief Executive Officer
Chief Executive Officer
2022
Former (2)
EC
Eva Camilla Nilsson
Chief Auditor
Chief Auditor
2021 – 2022
IH
Inger Helene Olsson
Chief Executive Officer
Chief Executive Officer
2021 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
JA
Johan Anders Mikael Havsjö
Chairman
2022
AM
Anita Maria Ulrica Karlsson
Board of Directors
2021
RR
Robin Reinholdt Sortebech
Board of Directors
2026
JT
Jan Tomas Wahlström
Chairman
2026
AS
Anna Sabina Maj Berlin
Board of Directors
2026
Former (1)
AJ
Anders Jan Reisch
Chairman
2021 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Level Bio AB (publ)
Company
100%
100%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on CyberGene Aktiebolag
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network